Síndrome Postcementación Ósea. Serie de Casos / Bone Cement Implantation Syndrome. Case Series

Introducción El síndrome de implantación de cemento óseo (SICO) es una complicacion intraoperatoria frecuente y potencialmente devastadora en pacientes sometidos a artroplastia de cadera cementada. Objetivo Describir la frecuencia del SICO en pacientes llevados a artroplastia total o parcial de cadera, mayores de 50 años, en el Hospital de San José de Bogotá, entre el 1 de enero del 2012 al 31 de Enero del 2018. Metodología Estudio serie de casos. Se revisaron los registros médicos de pacientes adultos mayores de 50 años con indicación de Artroplastia o Hemiatroplastia. Se analizaron las variables perioperatorias a través del registro de Anestesia. Mediante la clasificación de Donaldson se determinó el grado de SICO. Se emplearon estadísticas descriptivas y análisis de correspondencias múltiples para explorar la relación entre las variables. Resultados Incluimos 49 pacientes con una media de edad de 78 años (DE +/- 9.9), 39 eran mujeres (79.6%) y 37 (75.5%) tuvieron una clasificacion ASA II. Documentamos la presencia de SICO en 8 pacientes (16.3%): de los cuales 5 correspondian a Grado 1, 2 Grado 2 y 1 a Grado 3 con requerimiento de UCI. 7 eran mujeres; todos tenían antecedente de hipertension arterial, 2 diabetes mellitus, 2 EPOC y 1 osteoporosis. Ninguno reportó ingesta de Warfarina. Conclusiones SICO es un fenómeno frecuente en la artroplastia y hemiartroplastia cementada, siendo mayor en el sexo femenino, documentandose la presencia de predictores de severidad clasificacion ASA II ­III y el antecedente de EPOC en nuestro hospital.

Background The bone cement implantation syndrome (BCIS) is a frequent and potentially devastating intraoperative complication in patients undergoing cemented hip arthroplasty. The objective of study is to describe the frequency of BCIS in patients undergoing total or partial hip arthroplasty. Methods Case series study. We reviewed the medical records of adult patients over 50 years of age with an indication for Arthroplasty or Hemiatroplasty. The perioperative variables were analyzed through the Anesthesia registry. The degree of SICO was determined by Donaldson classification. Descriptive statistics and multiple correspondence analysis were used to explore the relationship between the variables. Results We included 49 patients with an average age of 78 years (SD +/- 9.9), 39 were women (79.6%) and 37 (75.5%) had an ASA II classification. We documented the presence of SICO in 8 patients (16.3%): of which 5 corresponded to Grade 1, 2 Grade 2 and 1 to Grade 3 with ICU requirement. 7 were women; all were hypertensive, 2 diabetes mellitus, 2 COPD and 1 osteoporosis. None reported Warfarin ingestion. Discussion BCIS is a frequent phenomenon in the arthroplasty and cemented hemiarthroplasty, being higher in the female sex, documenting the presence of predictors of severity ASA II -III classification and the history of COPD in our hospital.

Protective effect of creatine phosphate sodium pretreatment on circulatory function in total knee replace-ment surgery using bone cement implantation / 临床麻醉学杂志

Objective This study is to investigate the protective effect of creatine phosphate so-dium on circulatory function in unilateral total knee replacement surgery using bone cement implanta-tion.Methods Forty patients undergoing unilateral total knee replacement surgery with bone cement were randomly assigned into 2 groups:test group (group CP,n=20)and control group (group NS, n=20).The easophageal doppler ultrasound probe was placed at the level of the third rib transorally after induction in each patient.In group CP,creatine phosphate sodium (2 g in 100 ml normal saline) was infused (within 30 min)at 30 min before the operation,as well as normal saline 100 ml in group NS.SBP,DBP,HR,SpO2 ,PET CO2 and BIS were monitored and recorded before (T0 )and 1 (T1 ),3 (T2 ),5 (T3 ),10 (T4 )min after insertion of bone cement.Cardiac output (CO),stroke volume (SV)and left ventricular end-diastolic volume (LVEDV)were simultaneously monitored and recorded with esophageal doppler ultrasound.WhileⅡ-lead electrocardiogram were recorded to monitor ven-tricular arrhythmia perioperatively.Results SBP,DBP and HR decreased at T2 and T3 in group NS, and were lower than those in group CP (P <0.05 );Meanwhile,compared with group CP,CO and SV were significantly lower,while LVEDV was significantly higher in group NS (P <0.05 ).Com-pared with T0 ,CO and SV decreased and LVEDV increased at T2 and T3 in group NS (P <0.05 ). After insertion of bone cement,the incidence of arrhythmia in group CP was obviously lower than that in group NS (P < 0.05 ).Conclusion Pretreatment with creatine phosphate sodium can effectively prevent the incidence of bone cement implantation syndrome (BCIS)by stabilizing hemodynamic in elderly patients undergoing total knee replacement with bone cement.

Epinephrine hydrochloride prevents bone cement implantation syndrome in cemented hip replacement / 中华创伤杂志

Objective To investigate the clinical application of epinephrine hydrochloride in the prevention of bone cement implantation syndrome in the cemented hip replacement. Methods The clinical data of 48 patients treated with cemented hip replacement from July 2008 to April 2009 were retrospectively analyzed. All the patients were divided into control group and intervention group. The bone marrow cavities of 24 patients in the control group were not pretreated with saline epinephrine hydrochloride before implantation of bone cement; the bone marrow cavities of 24 patients in the intervention group were pretreated with saline epinephrine hydrochloride before implantation of bone cement. Systolic blood pressure (SBP), diastolic blood pressure (DBP), the mean arterial pressure (MAP), heart rate (HR)and pulse oxygen saturation ( SPO2 ) were compared between the two groups before bone cement implantation and 1,2, 3, 4, 5, 6, 7, 8, 9, 10 minutes after bone cement implantation. The data were analyzed with variance analysis and Q test. Results (1) In the control group: the blood pressure was decreased in control group one minute after bone cement implantation and a significant decrease of the blood pressure was observed at 2-6 minutes after the implantation ( P ＜ 0. 01 ). The blood pressure was increased seven minutes after the implantation, with the most significant increase of DBP ( P ＜ 0.05 ).The blood pressure recovered to normal 10 minutes later. The SPO2 was decreased significantly ( P ＜0.05 ) but no significant change was observed in HR ( P ＞ 0.05). (2) In the intervention group: the bone marrow cavity was pretreated with saline epinephrine hydrochloride before implantation of bone cement.ity. No significant difference was found in SBP, DBP, MAP, HR and SPO2 at different time points before and after bone cement implantation (P ＞0.05 ). Significant decrease of blood pressure and SPO2 was observed in control group and a significant hemodynamic change was detected at 2-6 minutes after the bone cement implantation. In the intervention group, no hemodynamic change was found in all the patients except that one patient was found with decrease of blood pressure and another one with the occasional premature ventricular contractions. Conclusion Pretreatment of bone marrow cavity with saline epinephrine hydrochloride can effectively prevent bone cement implantation syndrome.